MyFinsight
Home
Compare
About
Recent SEC Filings
10/16
Accenture plc
(ACN)
10/16
TRAVELERS COMPANIES, INC.
(TRV)
10/15
MARSH & MCLENNAN COMPANIES, INC.
(MRSH)
10/13
DOMINOS PIZZA INC
(DPZ)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/16
Accenture plc
(ACN)
10/16
TRAVELERS COMPANIES, INC.
(TRV)
10/15
MARSH & MCLENNAN COMPANIES, INC.
(MRSH)
10/13
DOMINOS PIZZA INC
(DPZ)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$392,749K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from equity offerings
Change in fair value of 2022 usd...
Maturity of investments
Others
Negative Cash Flow Breakdown
Purchases of investments
Total other income/(expense), ne...
Payment of equity offering costs
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
Research And Development
48,665
41,484
117,665
General And Administrative
26,412
17,736
48,644
Loss from operations
-75,077
-59,220
-166,309
Total other income/(expense), net
-83,909
-17,878
-17,484
Net loss
-158,986
-77,098
-183,793
Stock-based compensation
9,639
7,132
20,096
Change in fair value on directors' deferred share units ('ddsu')
-5,213
-1,030
-1,460
Amortization of intangible assets
-
-
0
Change in fair value of 2022 usd financing warrants
86,231
20,046
22,831
Gain on extinguishment of contribution payable
-
-
0
Accretion of discount on investments, net
1,364
-591
1,821
Unrealized foreign exchange
11
-
0
Other non-cash adjustments
216
220
230
Prepaid and other current assets
264
-585
-152
Other noncurrent assets
133
-118
-30
Accounts payable
-162
1,780
3,337
Accrued expenses
6,853
2,994
5,958
Other liabilities, long-term
10
29
40
Net cash used in operating activities
-52,778
-42,631
-131,560
Purchases of investments
355,738
0
268,356
Maturity of investments
39,000
42,000
116,750
Net cash used in investing activities
-316,738
42,000
-151,606
Proceeds from equity offerings
805,000
-
258,858
Payment of equity offering costs
46,418
-
15,946
Proceeds from credit facility
0
-
42,000
Repayment of credit facility
0
-
22,000
Payment of credit facility issuance costs
0
-
447
Proceeds from the 2022 atm net of issuance costs
-
-
0
Payment of deferred financing fees related to 2024 atm
-
-
0
Proceeds from exercise of pre-funded warrants
5
4
-
Proceeds from exercise of 2022 usd financing warrants
2,819
3,833
3,767
Proceeds from exercise of options
860
1,196
625
Proceeds from issuance of common shares under espp
0
276
412
Withholding taxes paid on vested rsus
-
-
0
Net cash provided by financing activities
762,266
5,309
267,269
Effect of exchange rate changes on cash
-1
3
-7
Net increase/(decrease) in cash and cash equivalents
392,749
4,681
-15,904
Cash and cash equivalents, beginning of period
262,518
257,837
273,741
Cash and cash equivalents, end of period
655,267
262,518
257,837
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
DFTX Cash Flow Sankey Diagram
Sankey diagram visualizing DFTX cash flow for the period
Proceeds from equity
offerings
$805,000K
Proceeds from exercise of
2022 usd financing...
$2,819K
Proceeds from exercise of
options
$860K
Proceeds from exercise of
pre-funded warrants
$5K
Net cash provided by
financing activities
$762,266K
Canceled cashflow
$46,418K
Net
increase/(decrease) in cash and cash...
$392,749K
Canceled cashflow
$369,517K
Payment of equity
offering costs
$46,418K
Maturity of investments
$39,000K
Change in fair value of
2022 usd financing...
$86,231K
Stock-based compensation
$9,639K
Accrued expenses
$6,853K
Change in fair value on
directors' deferred share...
-$5,213K
Other non-cash
adjustments
$216K
Net cash used in
investing activities
-$316,738K
Net cash used in
operating activities
-$52,778K
Effect of exchange rate
changes on cash
-$1K
Canceled cashflow
$39,000K
Canceled cashflow
$108,152K
Purchases of investments
$355,738K
Net loss
-$158,986K
Accretion of discount on
investments, net
$1,364K
Prepaid and other
current assets
$264K
Accounts payable
-$162K
Other noncurrent
assets
$133K
Unrealized foreign
exchange
$11K
Other liabilities,
long-term
$10K
Total other
income/(expense), net
-$83,909K
Loss from operations
-$75,077K
Research And Development
$48,665K
General And
Administrative
$26,412K
Buy us a coffee